BOLD (Boundless Bio, Inc. Common Stock) Stock Analysis - Analyst Ratings

Boundless Bio, Inc. Common Stock (BOLD) is a publicly traded Healthcare sector company. As of May 21, 2026, BOLD trades at $1.42 with a market cap of $31.90M and a P/E ratio of -0.55. BOLD moved +0.00% today. Year to date, BOLD is +20.34%; over the trailing twelve months it is -14.46%. Its 52-week range spans $0.96 to $3.75. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces BOLD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate BOLD?

1 analysts cover BOLD: 0 strong buy, 0 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $0.00.

BOLD Key Metrics

Key financial metrics for BOLD
MetricValue
Price$1.42
Market Cap$31.90M
P/E Ratio-0.55
EPS$-2.60
Dividend Yield0.00%
52-Week High$3.75
52-Week Low$0.96
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-58.20M
Gross Margin0.00%

BOLD Analyst Consensus

1 analysts cover BOLD: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.

Latest BOLD News

Recent BOLD Insider Trades

  • Burow Kristina bought 66.67K (~$1.07M) on Apr 2, 2024.
  • Burow Kristina bought 133.33K (~$2.13M) on Apr 2, 2024.
  • CRANDELL KEITH bought 66.67K (~$1.07M) on Apr 2, 2024.

Common questions about BOLD

What do analysts rate BOLD?
1 analysts cover BOLD: 0 strong buy, 0 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $0.00.
Does Rallies show BOLD price targets?
Yes. Rallies tracks BOLD analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is BOLD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BOLD. It does not provide personalized investment advice.
BOLD

BOLD